Nivolumab 600mg/5ml solution for injection vials
NHS hospitals in England used £106,614,730 of indicative cost of Nivolumab 600mg/5ml solution for injection vials in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is up 50.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nivolumab 600mg/5ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nivolumab 600mg/5ml solution for injection vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Colchester Hospital University Nhs Ft | £14,147,109 |
| The Christie Nhs Foundation Trust | £9,046,988 |
| The Clatterbridge Cancer Centre Nhs Ft | £6,207,561 |
| East And North Hertfordshire Nhs Trust | £5,868,957 |
| Leeds Teaching Hpls Nhs Trust | £4,399,743 |
| Hull And East Yorkshire Hpls Nhs Trust | £3,836,281 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,749,392 |
| Royal Free London Nhs Foundation Trust | £3,599,311 |
| Western Sussex Hospitals Nhs Found Trust | £3,391,304 |
| Nottingham University Hospitals Trust | £3,083,243 |
The primary-care picture
Nivolumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Nivolumab medicine page.